# Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

> **NCT00707083** · PHASE3 · COMPLETED · sponsor: **Prince of Wales Hospital, Shatin, Hong Kong** · enrollment: 2231 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00707083
- **Lead sponsor:** Prince of Wales Hospital, Shatin, Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 2231 (ACTUAL)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707083, "Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00707083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*